Krishnan-Shah Family Professor of Chemical and Systems Biology,
Stanford University, Stanford, CA
For pioneering innovative structure-based chemical biology approaches to designing and developing protein inhibitors and degraders that have revolutionized the future of cancer therapeutics; and for spearheading novel combinatorial chemistry and genomic approaches that have resulted in the development of several cancer therapies, including ceritinib, osimertinib, and purvalanol.
This award was established in 2007 to recognize outstanding, novel, and significant chemistry research, which has led to important contributions in basic cancer research; translational cancer research; cancer diagnosis; the prevention of cancer; or the treatment of patients with cancer. To learn more please visit the press release.
View Dr. Gray’s Fellows of the AACR Academy Page.
View Past Recipients.